Can-Fite BioPharma Ltd. 6-K filing
Filed 2025-08-28 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-081407
- Form type
- 6-K
- CIK
- 0001536196
- Primary document
- https://www.sec.gov/Archives/edgar/data/1536196/000121390025081407/ea0254606-6k_canfite.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Can-Fite BioPharma Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $202,000 | - | - |
| Operating Income | $-4.9M | - | - |
| Net Income | $-4.9M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $6.5M | - | - |
| Total Assets | $7.7M | - | - |
| Shareholders Equity | $4.2M | - | - |
| Operating Cash Flow | $-4.8M | - | - |
| Capital Expenditures | $1,000 | - | - |